Prince Charles gives a speech at AstraZeneca's Discovery Centre (DISC) unveiling, with Pascal Soriot
Eight years and $1.3B later, AstraZeneca finally unveils Cambridge R&D palace
One of the biggest projects that Pascal Soriot initiated, all the way back in 2013, after he first took over as AstraZeneca’s CEO is finally complete.
AstraZeneca is formally unveiling its $1.34 billion (£1 billion) R&D campus in Cambridge, UK, a shiny new facility spanning 19,000 square meters in the southern part of the city. On top of 2,200 research scientists, it will also host a suite of robotics, high-throughput screening and AI-driven technology.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
